Taiwan · Delayed Price · Currency is TWD EirGenix Statistics
Total Valuation
EirGenix has a market cap or net worth of TWD 15.05 billion. The enterprise value is 13.90 billion.
| Market Cap | 15.05B |
| Enterprise Value | 13.90B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EirGenix has 302.88 million shares outstanding. The number of shares has decreased by -1.27% in one year.
| Current Share Class | 302.88M |
| Shares Outstanding | 302.88M |
| Shares Change (YoY) | -1.27% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 1.51% |
| Owned by Institutions (%) | 8.06% |
| Float | 193.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.41 |
| PB Ratio | 1.93 |
| P/TBV Ratio | 2.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 26.48 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 0.22.
| Current Ratio | 3.45 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.65 |
| Interest Coverage | -100.68 |
Financial Efficiency
Return on equity (ROE) is -7.00% and return on invested capital (ROIC) is -13.09%.
| Return on Equity (ROE) | -7.00% |
| Return on Assets (ROA) | -5.10% |
| Return on Invested Capital (ROIC) | -13.09% |
| Return on Capital Employed (ROCE) | -9.05% |
| Weighted Average Cost of Capital (WACC) | 5.40% |
| Revenue Per Employee | 1.21M |
| Profits Per Employee | -568,894 |
| Employee Count | 1,000 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 1.46 |
Taxes
In the past 12 months, EirGenix has paid 171,000 in taxes.
| Income Tax | 171,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.70% in the last 52 weeks. The beta is 0.31, so EirGenix's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -18.70% |
| 50-Day Moving Average | 48.00 |
| 200-Day Moving Average | 55.92 |
| Relative Strength Index (RSI) | 53.73 |
| Average Volume (20 Days) | 732,009 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EirGenix had revenue of TWD 1.21 billion and -568.89 million in losses. Loss per share was -1.89.
| Revenue | 1.21B |
| Gross Profit | 361.09M |
| Operating Income | -857.75M |
| Pretax Income | -568.72M |
| Net Income | -568.89M |
| EBITDA | -633.50M |
| EBIT | -857.75M |
| Loss Per Share | -1.89 |
Balance Sheet
The company has 2.86 billion in cash and 1.70 billion in debt, with a net cash position of 1.16 billion or 3.82 per share.
| Cash & Cash Equivalents | 2.86B |
| Total Debt | 1.70B |
| Net Cash | 1.16B |
| Net Cash Per Share | 3.82 |
| Equity (Book Value) | 7.79B |
| Book Value Per Share | 25.71 |
| Working Capital | 2.77B |
Cash Flow
In the last 12 months, operating cash flow was 568.50 million and capital expenditures -1.21 billion, giving a free cash flow of -642.15 million.
| Operating Cash Flow | 568.50M |
| Capital Expenditures | -1.21B |
| Depreciation & Amortization | 224.26M |
| Net Borrowing | 453.56M |
| Free Cash Flow | -642.15M |
| FCF Per Share | -2.12 |
Margins
Gross margin is 29.76%, with operating and profit margins of -70.69% and -46.89%.
| Gross Margin | 29.76% |
| Operating Margin | -70.69% |
| Pretax Margin | -46.87% |
| Profit Margin | -46.89% |
| EBITDA Margin | -52.21% |
| EBIT Margin | -70.69% |
| FCF Margin | n/a |
Dividends & Yields
EirGenix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.27% |
| Shareholder Yield | 1.27% |
| Earnings Yield | -3.78% |
| FCF Yield | -4.27% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |